{
    "medicine_id": "d1d7050586b87596a22c7c38dbf473769e7aba2f",
    "platform_id": "9980",
    "metadata": {
        "name": "Darunavir Dr Reddy s 800 mg Film Coated Tablets",
        "composition": "Each film coated tablet contains 800 mg of darunavir as darunavir propylene glycolate",
        "clinical_particulars": {
            "therapeutic_indications": "Darunavir co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus HIV 1 infection Darunavir 800 mg tablets may be used to provide suitable dose regimens for the treatment of HIV 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Patients with severe Child Pugh Class C hepatic impairment Concomitant treatment with any of the following medicinal products given the expected decrease in plasma concentrations of darunavir ritonavir and cobicistat and the potential for loss of therapeutic effect see sections 4 4 and 4 5 Applicable to darunavir boosted with either ritonavir or cobicistat Applicable to darunavir boosted with cobicistat not when boosted with ritonavir Strong CYP3A inducers include e g carbamazepine phenobarbital and phenytoin see sections 4 4 and 4 5 Darunavir boosted with either ritonavir or cobicistat inhibits the elimination of active substances that are highly dependent on CYP3A for clearance which results in increased exposure to the co administered medicinal product Therefore concomitant treatment with such medicinal products for which elevated plasma concentrations are associated with serious and or life threatening events is contraindicated applies to darunavir boosted with either ritonavir or cobicistat These active substances include e g",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Internal Phase;Lactose monohydrate;Microcrystalline cellulose;Povidone K30;Crospovidone;Silica, colloidal anhydrous;External Phase;Magnesium Stearate;Polyvinyl Alcohol(E1203);Macrogols (E1521);Iron Oxide Red (E172);Talc (E553b);Titanium dioxide (E171)",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2021-06-21"
    }
}